Bracco lands FDA nod for barium radiography contrast

AuntMinnie.com staff writers

Feb 1, 2016

Contrast developer Bracco Diagnostics has received U.S. Food and Drug Administration (FDA) approval for the use of its E-Z-HD barium sulfate contrast agent in double-contrast radiography examinations of the esophagus, stomach, and duodenum.

The approval, which applies to visualizing the gastrointestinal tract in patients 12 years and older, is the first in a series of new drug approvals Bracco is pursuing for its entire line of barium sulfate contrast agents, according to the company. E-Z-HD is produced for Bracco by E-Z-EM Canada.

PET/MRI reveals sex differences in patients with autism

April 18, 2024

Doctor Female Young Desk 400

Radiologist consultation improves patients' LCS attitudes

April 18, 2024

IMV’s Oncology in Diagnostic Imaging Market Outlook Report

IMV’s Oncology in Diagnostic Imaging Market Outlook Report

March 15, 2024

Test set images with ground truth (teal, red) and model predictions (green, yellow), with true positives (green), false positives (yellow), and false negatives (red). Predictions from the 6x-YOLOv5 ensemble trained on histogram equalized input images with a y = 0.2 avalanche scheme, achieving 0.536 precision, 0.795 recall, and 0.723 F2 score. Image and caption courtesy of Scientific Reports.

AI proposed to help radiologists detect child abuse injuries

April 17, 2024

PET/MRI reveals sex differences in patients with autism

PET/MRI shows that young women with autism spectrum disorder have increased brain metabolism associated with translocator protein.

April 18, 2024

Radiologist consultation improves patients' LCS attitudes

By Kate Madden Yee

Consulting with a radiologist boosts patients' attitudes toward lung cancer screening (LCS) and their interest in quitting smoking, researchers have reported.

April 18, 2024

Doctor Female Young Desk 400

PET tracer for gliomas under expedited review

By AuntMinnie.com staff writers

The U.S. Food and Drug Administration (FDA) has granted fast-track designation to Telix Pharmaceuticals’ PET radiotracer F-18 floretyrosine (Pixclara) for imaging progressive or recurring gliomas.

April 17, 2024

AI proposed to help radiologists detect child abuse injuries

A team at Michigan State University has developed an AI model designed to detect rib fractures in children under 3 years old.

April 17, 2024

Test set images with ground truth (teal, red) and model predictions (green, yellow), with true positives (green), false positives (yellow), and false negatives (red). Predictions from the 6x-YOLOv5 ensemble trained on histogram equalized input images with a y = 0.2 avalanche scheme, achieving 0.536 precision, 0.795 recall, and 0.723 F2 score. Image and caption courtesy of Scientific Reports.

Tailored lung cancer screening model helps determine nodule follow-up

By Kate Madden Yee

A personalized lung cancer screening model used with patients with pulmonary nodules identified on low-dose CT helps clinicians determine how to follow up better than rule-based protocols, researchers have found.

April 17, 2024

POCUS used widely in lung ultrasound applications

By Amerigo Allegretto

Some of the top domains for users of point-of-care ultrasound (POCUS) incorporate the technology for lung ultrasound applications.

April 17, 2024

Screenshot (1142)

CT-based deep learning identifies patients at further lung cancer risk

By Kate Madden Yee

A CT-based deep learning model can identify individuals with clinical stage IA non-small cell lung cancer (NSCLC) at high risk of further disease, researchers have found.

April 16, 2024

Deep-learning model determines breast tumor staging

By Amerigo Allegretto

A deep-learning model based on mammographic images can determine tumor staging and sentinel lymph node metastasis in breast cancer patients.

April 16, 2024

Researchers explain the data preparation and structure of a proposed CNN-based deep learning model using mammography features to determine breast tumor staging. The image is available for use under a Creative Commons license: CC BY-NC-ND 4.0 DEED Attribution-NonCommercial-NoDerivs 4.0 International.

FAPI-PET shows promise in patients with lung cancer

FAPI-PET imaging could emerge as a new tool for assessing patients with single pulmonary tumors, especially in those with negative results on other scans.

April 15, 2024

F-18 FDG and Ga-68 FAPI-46 images of a 51-year-old woman with adenocarcinoma with lepidic growth pattern in right upper lobe. (A) Maximum-intensity-projection PET images. The lesion had F-18 FDG uptake below blood pool level but was strongly Ga-68 FAPI-46-positive. CT-guided biopsy led to pathologic diagnosis of adenocarcinoma, and the patient was treated by stereotactic body radiation therapy because of functional inoperability. Image courtesy of the Journal of Nuclear Medicine.

Can brain MRI for emergency imaging of dizziness be more effective?

By Kate Madden Yee

Predictors for acute conditions such as stroke could make brain MRI more effective in patients who present in the emergency department with dizziness or vertigo, according to recent research.

April 15, 2024

RadNet teams up with basketball icon Sheryl Swoopes

By AuntMinnie.com staff writers

RadNet has tapped basketball legend and WNBA superstar Sheryl Swoopes as spokesperson for its nationwide breast cancer screening programs.

April 12, 2024

Vision transformer AI model boosts PET/CT imaging of cancer

A vision transformer AI model outperformed convolutional neural networks when classifying tumors on PET/CT images as benign or malignant.

April 12, 2024

Predictions and Grad-CAMs of ViT-based models on sample PET/CT, PET, and CT test images from the “positive” class. ViT was fine-tuned using training data for each modality. The bounding boxes depicted in the figure indicate malignant lesions. The top row of the Grad-CAMs shows important areas for “positive” predictions, and the bottom row shows areas for “negative” predictions. Image courtesy of Scientific Reports.

Page 1 of 3587